Financial Statements

STAAR Surgical Company (STAA)


-0.07 (-0.11%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2022 2021 2020 2018
Retained Earnings (Previous Year) -111-142--
Net Income 3925145
Stock Dividends -6-156-161
Dividend Paid ----
Retained Earnings -73-111-142-156

PPE Schedule

Year 2022 2021 2020 2018
Gross PPE 6826--
Annual Depreciation 32563614
Capital Expenditure -18-14-10-2
Net PPE 82682611

Intangible and Goodwill Schedule

Year 2022 2021 2020 2018
Intangible and Goodwill (Previous Year) --22
New Purchases ----156
Intangible and Goodwill 2222

STAAR Surgical Company income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes STAAR Surgical Company FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.